The latest Medical Device Tech Watch assesses new technology to combat atrial fibrillation and offers a glimpse of how artificial intelligence will help process remote monitoring data.
Yesterday on Capitol Hill, Vizient, Inc. held a policy briefing titled, “Communities in Crisis: How Hospitals are Addressing Mental and Behavioral Health Challenges in their Communities” at the Rayburn House Office Building.
Vizient responds to Centers for Medicare and Medicaid Services’ (CMS) final remedy for its unlawful 340B payment cuts from 2018 through a majority of 2022.
Vizient today announced it has completed its acquisition of PrefTech OR, a next-generation, cloud-based preference card management software that helps healthcare providers optimize their operating rooms to increase workflow efficiency, lower costs and impr...
This is Vizient’s second year in a row to be named to this prestigious list, and it means that Vizient is one of the best companies to work for in the country.
Vizient, Inc. offered feedback in response to the Administration’s proposed rule on updating requirements for the Mental Health Parity and Addiction Equity Act of 2008.
Vizient, Inc. offered feedback in response to the House Ways and Means Committee's Request for Information on improving healthcare in rural and underserved areas.
The awards recognize the work of Vizient provider customers in clinical quality and accountability, supplier diversity and environmentally preferred sourcing excellence and were presented during the 2023 Vizient Connections Summit in Las Vegas.
Vizient presented the awards at its annual Connections Summit in Las Vegas to recognize suppliers and distributors for delivering exceptional service to Vizient customer providers.
Vizient, Inc. pharmacy experts will speak at the Food and Drug Administration’s (FDA) Compounding Quality Center of Excellence 2023 Virtual Conference on September 12-13.
Vizient, Inc. submitted comments on the Centers for Medicare and Medicaid Services (CMS) CY 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Physician Fee Schedule (PFS) proposed rules.
Medical Device Tech Watch: With the migration of musculoskeletal procedures to the outpatient setting, inpatient providers can mitigate the volume loss with targeted ambulatory strategies. This edition of Tech Watch also surveys treatment options for diabe...
The report, which utilizes data from Medicare’s Qualified Entity Program, explores outcomes through the lens of high social need communities, evaluating the cost and quality of care provided to patients with chronic kidney disease and end stage renal disea...
A Vizient white paper demonstrates how the lack of information about medication access across the supply chain is exacerbating the shortage of seven oncology drugs used to treat a multitude of cancers.
Vizient announced it has published its annual corporate responsibility report detailing its focus on driving positive impacts across three interconnected pillars – people, places, and planet – by leveraging its unique position in the healthcare industry to...
The access comes at no cost and provides a unique level of visibility for healthcare organizations to assess social determinants of health that impact health equity in the communities they serve. It is now available to anyone.
Vizient, Inc. offers a statement in response to the Centers for Medicare and Medicaid Services (CMS) CY 2024 Outpatient Prospective Payment System (OPPS) Proposed Rule
Yesterday on Capitol Hill, Vizient, Inc. hosted a policy briefing titled, "Beyond the Four Walls: How Hospitals are Addressing Social Determinants of Health," at the Rayburn House Office Building.
Sg2, a Vizient company, released its 2023 Impact of Change Forecast, projecting hospital capacity challenges will continue into the next decade, driven by higher patient acuity and staffing shortages.